KPCM
TMO icon

Kings Point Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Kings Point Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$25.4M Sell
43,072
-6,370
-13% -$3.66M 2.21% 7
2021
Q4 		$33M Sell
49,442
-2,418
-5% -$1.51M 2.7% 6
2021
Q3 		$29.6M Buy
51,860
+1,158
+2% +$636K 2.63% 6
2021
Q2 		$25.6M Sell
50,702
-405
-0.8% -$191K 2.32% 7
2021
Q1 		$23.3M Buy
51,107
+1,268
+3% +$605K 2.3% 8
2020
Q4 		$23.2M Buy
49,839
+304
+0.6% +$143K 2.47% 7
2020
Q3 		$21.9M Buy
49,535
+357
+0.7% +$147K 2.73% 6
2020
Q2 		$17.8M Buy
49,178
+562
+1% +$188K 2.58% 6
2020
Q1 		$13.8M Buy
48,616
+1,857
+4% +$586K 2.43% 6
2019
Q4 		$15.2M Buy
46,759
+540
+1% +$164K 2.24% 6
2019
Q3 		$13.5M Sell
46,219
-68
-0.1% -$19.5K 2.28% 7
2019
Q2 		$13.6M Buy
46,287
+101
+0.2% +$27.8K 2.48% 4
2019
Q1 		$12.6M Sell
46,186
-431
-0.9% -$107K 2.51% 5
2018
Q4 		$10.4M Sell
46,617
-1,023
-2% -$240K 2.33% 5
2018
Q3 		$11.6M Sell
47,640
-1,033
-2% -$238K 2.17% 6
2018
Q2 		$10.1M Sell
48,673
-18
-0% -$3.82K 1.99% 10
2018
Q1 		$10.1M Buy
48,691
+1,448
+3% +$304K 2.03% 8
2017
Q4 		$8.97M Buy
47,243
+1,361
+3% +$261K 1.89% 11
2017
Q3 		$8.68M Sell
45,882
-583
-1% -$106K 1.94% 11
2017
Q2 		$8.11M Sell
46,465
-761
-2% -$128K 1.89% 14
2017
Q1 		$7.25M Sell
47,226
-2,986
-6% -$456K 1.7% 22
2016
Q4 		$7.08M Sell
50,212
-915
-2% -$135K 1.75% 21
2016
Q3 		$8.13M Sell
51,127
-8,068
-14% -$1.24M 2.15% 13
2016
Q2 		$8.75M Sell
59,195
-3,201
-5% -$472K 2.24% 10
2016
Q1 		$8.84M Buy
62,396
+2,386
+4% +$320K 2.25% 13
2015
Q4 		$8.51M Buy
60,010
+927
+2% +$124K 2.11% 15
2015
Q3 		$7.22M Buy
59,083
+1,991
+3% +$259K 1.9% 16
2015
Q2 		$7.41M Buy
57,092
+1,796
+3% +$234K 1.79% 21
2015
Q1 		$7.43M Buy
55,296
+2,860
+5% +$369K 1.86% 21
2014
Q4 		$6.57M Buy
52,436
+2,360
+5% +$287K 1.77% 22
2014
Q3 		$6.09M Sell
50,076
-738
-1% -$89.7K 1.84% 22
2014
Q2 		$6M Buy
50,814
+25,397
+100% +$2.99M 1.8% 24
2014
Q1 		$3.06M Buy
+25,417
New +$3.02M 1% 40

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kings Point Capital Management's TMO Position: Q1 2022 in Review

Kings Point Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q1 2022, selling an estimated $3.66M and leaving 43,072 shares worth $25.4M. The position accounts for 2.21% of the portfolio, ranked #7.

Kings Point Capital Management first reported a position in TMO in Q1 2014 and has held it in 33 quarters since. The position peaked at $33M in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Kings Point Capital Management held 43,072 shares of Thermo Fisher Scientific worth $25.4M as of Q1 2022.
  • Kings Point Capital Management sold 6,370 Thermo Fisher Scientific shares in Q1 2022, an estimated $3.66M.
  • Thermo Fisher Scientific made up 2.21% of Kings Point Capital Management's portfolio in Q1 2022, its #7 holding.
  • Kings Point Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 33 quarters since.
  • Kings Point Capital Management's Thermo Fisher Scientific position peaked at $33M in Q4 2021.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.